Journal article
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001
Abstract
BACKGROUND/OBJECTIVES: Although thromboembolism (TE) is a serious complication in patients with acute lymphoblastic leukemia (ALL), thromboprophylaxis is not commonly used due to the inherent bleeding risk in this population. Identifying prothrombotic risk factors will help target thromboprophylaxis to those at highest thrombotic risk. We aimed to define predictors and the impact of TE on ALL outcome in children (1-18 years) treated on the …
Authors
Athale UH; Flamand Y; Blonquist T; Stevenson KE; Spira M; Asselin BL; Clavell LA; Cole PD; Kelly KM; Laverdiere C
Journal
Pediatric Blood & Cancer, Vol. 69, No. 8,
Publisher
Wiley
Publication Date
8 2022
DOI
10.1002/pbc.29581
ISSN
1545-5009